CTLA4 and neoplasm: In a separate study using KPC mice, depletion of FAP+ stromal cells was synergistic with anti‐CTLA‐4 or anti‐PD‐L1 therapy, further demonstrating the role of stroma in suppressing anti‐tumor immunity.50